Ancora Advisors, LLC Seagen Inc. Transaction History

Ancora Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $57,042 - $62,700	304 New	304 $58,000
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $5,875 - $9,683	-54 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $6,458 - $8,523	54 New	54 $8,000
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $7,415 - $9,786	-62 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $8,839 - $11,833	62 New	62 $10,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.